Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging

Chi-Tai Yeh, Yerra Koteswara Rao, Min Ye, Wen Shi Wu, Tung Chen Chang, Liang Shun Wang, Chih Hsiung Wu, Alexander T H Wu, Yew Min Tzeng

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In continuation to our studies toward the identification of direct anti-cancer targets, here we showed that destruxin B (DB) from Metarhizium anisopliae suppressed the proliferation and induced cell cycle arrest in human colorectal cancer (CRC) HT29, SW480 and HCT116 cells. Additionally, DB induced apoptosis in HT29 cells by decreased expression level of anti-apoptotic proteins Bcl-2 and Bcl-xL while increased pro-apoptotic Bax. On the other hand, DB attenuated Wnt-signaling by downregulation of β-catenin, Tcf4 and β-catenin/Tcf4 transcriptional activity, concomitantly with decreased expression of β-catenin target genes cyclin D1, c-myc and survivin. Furthermore, DB affected the migratory and invasive ability of HT29 cells through suppressed MMPs-2 and -9 enzymatic activities. We also found that DB targeted the MAPK and/or PI3K/Akt pathway by reduced expression of Akt, IKK-α, JNK, NF-κB, c-Jun and c-Fos while increased that of IκBα. Finally, we demonstrated that DB inhibited tumorigenesis in HT29 xenograft mice using non-invasive bioluminescence technique. Consistently, tumor samples from DB-treated mice demonstrated suppressed expression of β-catenin, cyclin D1, survivin, and endothelial marker CD31 while increased caspase-3 expression. Collectively, our data supports DB as an inhibitor of Wnt/β-catenin/Tcf signaling pathway that may be beneficial in the CRC management.

Original languageEnglish
Pages (from-to)31-41
Number of pages11
JournalToxicology and Applied Pharmacology
Volume261
Issue number1
DOIs
Publication statusPublished - May 15 2012

Fingerprint

Bioluminescence
Colorectal Neoplasms
Catenins
Neoplasm Metastasis
Imaging techniques
HT29 Cells
Cyclin D1
Metarhizium
bcl-1 Genes
HCT116 Cells
Apoptosis Regulatory Proteins
destruxin B
Cell Cycle Checkpoints
Matrix Metalloproteinases
Phosphatidylinositol 3-Kinases
Heterografts
Caspase 3
Tumors
Neoplasms
Carcinogenesis

Keywords

  • Apoptosis
  • Destruxin B
  • Human colorectal carcinoma
  • In vivo bioluminescence
  • Migration and invasion
  • Wnt-signaling pathway

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. / Yeh, Chi-Tai; Rao, Yerra Koteswara; Ye, Min; Wu, Wen Shi; Chang, Tung Chen; Wang, Liang Shun; Wu, Chih Hsiung; Wu, Alexander T H; Tzeng, Yew Min.

In: Toxicology and Applied Pharmacology, Vol. 261, No. 1, 15.05.2012, p. 31-41.

Research output: Contribution to journalArticle

@article{c82b6904e8d14a4a8ab2efead982282e,
title = "Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging",
abstract = "In continuation to our studies toward the identification of direct anti-cancer targets, here we showed that destruxin B (DB) from Metarhizium anisopliae suppressed the proliferation and induced cell cycle arrest in human colorectal cancer (CRC) HT29, SW480 and HCT116 cells. Additionally, DB induced apoptosis in HT29 cells by decreased expression level of anti-apoptotic proteins Bcl-2 and Bcl-xL while increased pro-apoptotic Bax. On the other hand, DB attenuated Wnt-signaling by downregulation of β-catenin, Tcf4 and β-catenin/Tcf4 transcriptional activity, concomitantly with decreased expression of β-catenin target genes cyclin D1, c-myc and survivin. Furthermore, DB affected the migratory and invasive ability of HT29 cells through suppressed MMPs-2 and -9 enzymatic activities. We also found that DB targeted the MAPK and/or PI3K/Akt pathway by reduced expression of Akt, IKK-α, JNK, NF-κB, c-Jun and c-Fos while increased that of IκBα. Finally, we demonstrated that DB inhibited tumorigenesis in HT29 xenograft mice using non-invasive bioluminescence technique. Consistently, tumor samples from DB-treated mice demonstrated suppressed expression of β-catenin, cyclin D1, survivin, and endothelial marker CD31 while increased caspase-3 expression. Collectively, our data supports DB as an inhibitor of Wnt/β-catenin/Tcf signaling pathway that may be beneficial in the CRC management.",
keywords = "Apoptosis, Destruxin B, Human colorectal carcinoma, In vivo bioluminescence, Migration and invasion, Wnt-signaling pathway",
author = "Chi-Tai Yeh and Rao, {Yerra Koteswara} and Min Ye and Wu, {Wen Shi} and Chang, {Tung Chen} and Wang, {Liang Shun} and Wu, {Chih Hsiung} and Wu, {Alexander T H} and Tzeng, {Yew Min}",
year = "2012",
month = "5",
day = "15",
doi = "10.1016/j.taap.2012.03.007",
language = "English",
volume = "261",
pages = "31--41",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging

AU - Yeh, Chi-Tai

AU - Rao, Yerra Koteswara

AU - Ye, Min

AU - Wu, Wen Shi

AU - Chang, Tung Chen

AU - Wang, Liang Shun

AU - Wu, Chih Hsiung

AU - Wu, Alexander T H

AU - Tzeng, Yew Min

PY - 2012/5/15

Y1 - 2012/5/15

N2 - In continuation to our studies toward the identification of direct anti-cancer targets, here we showed that destruxin B (DB) from Metarhizium anisopliae suppressed the proliferation and induced cell cycle arrest in human colorectal cancer (CRC) HT29, SW480 and HCT116 cells. Additionally, DB induced apoptosis in HT29 cells by decreased expression level of anti-apoptotic proteins Bcl-2 and Bcl-xL while increased pro-apoptotic Bax. On the other hand, DB attenuated Wnt-signaling by downregulation of β-catenin, Tcf4 and β-catenin/Tcf4 transcriptional activity, concomitantly with decreased expression of β-catenin target genes cyclin D1, c-myc and survivin. Furthermore, DB affected the migratory and invasive ability of HT29 cells through suppressed MMPs-2 and -9 enzymatic activities. We also found that DB targeted the MAPK and/or PI3K/Akt pathway by reduced expression of Akt, IKK-α, JNK, NF-κB, c-Jun and c-Fos while increased that of IκBα. Finally, we demonstrated that DB inhibited tumorigenesis in HT29 xenograft mice using non-invasive bioluminescence technique. Consistently, tumor samples from DB-treated mice demonstrated suppressed expression of β-catenin, cyclin D1, survivin, and endothelial marker CD31 while increased caspase-3 expression. Collectively, our data supports DB as an inhibitor of Wnt/β-catenin/Tcf signaling pathway that may be beneficial in the CRC management.

AB - In continuation to our studies toward the identification of direct anti-cancer targets, here we showed that destruxin B (DB) from Metarhizium anisopliae suppressed the proliferation and induced cell cycle arrest in human colorectal cancer (CRC) HT29, SW480 and HCT116 cells. Additionally, DB induced apoptosis in HT29 cells by decreased expression level of anti-apoptotic proteins Bcl-2 and Bcl-xL while increased pro-apoptotic Bax. On the other hand, DB attenuated Wnt-signaling by downregulation of β-catenin, Tcf4 and β-catenin/Tcf4 transcriptional activity, concomitantly with decreased expression of β-catenin target genes cyclin D1, c-myc and survivin. Furthermore, DB affected the migratory and invasive ability of HT29 cells through suppressed MMPs-2 and -9 enzymatic activities. We also found that DB targeted the MAPK and/or PI3K/Akt pathway by reduced expression of Akt, IKK-α, JNK, NF-κB, c-Jun and c-Fos while increased that of IκBα. Finally, we demonstrated that DB inhibited tumorigenesis in HT29 xenograft mice using non-invasive bioluminescence technique. Consistently, tumor samples from DB-treated mice demonstrated suppressed expression of β-catenin, cyclin D1, survivin, and endothelial marker CD31 while increased caspase-3 expression. Collectively, our data supports DB as an inhibitor of Wnt/β-catenin/Tcf signaling pathway that may be beneficial in the CRC management.

KW - Apoptosis

KW - Destruxin B

KW - Human colorectal carcinoma

KW - In vivo bioluminescence

KW - Migration and invasion

KW - Wnt-signaling pathway

UR - http://www.scopus.com/inward/record.url?scp=84860507443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860507443&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2012.03.007

DO - 10.1016/j.taap.2012.03.007

M3 - Article

C2 - 22465936

AN - SCOPUS:84860507443

VL - 261

SP - 31

EP - 41

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 1

ER -